共 7 条
[1]
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function.[J].David H. Barad;Andrea Weghofer;Norbert Gleicher.Fertility and Sterility.2009, 4
[3]
Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.[J].Jung Ryeol Lee;Seok Hyun Kim;Sun Mie Kim;Byung Chul Jee;Seung-Yup Ku;Chang Suk Suh;Young Min Choi;Jung Gu Kim;Shin Yong Moon.Fertility and Sterility.2008, 4
[4]
Changes in Serum Anti-Müllerian Hormone Level during Low-Dose Recombinant Follicular-Stimulating Hormone Therapy for Anovulation in Polycystic Ovary Syndrome.[J].Sophie Catteau-Jonard;Pascal Pigny;Anne-Céline Reyss;Christine Decanter;Edouard Poncelet;Didier Dewailly.The Journal of Clinical Endocrinology & Metabolism.2007, 11
[5]
Granulosa Cell Production of Anti-Müllerian Hormone Is Increased in Polycystic Ovaries.[J].Laura Pellatt;Laurine Hanna;Mark Brincat;Ray Galea;Henrietta Brain;Saffron Whitehead;Helen Mason.The Journal of Clinical Endocrinology & Metabolism.2007, 1
[6]
Elevated serum müllerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in vitro fertilization.[J].Gary S. Nakhuda;Micheline C. Chu;Jeff G. Wang;Mark V. Sauer;Rogerio A. Lobo.Fertility and Sterility.2006, 5
[7]
Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone; inhibin B; or estradiol.[J].André Hazout;Philippe Bouchard;David B. Seifer;P. Aussage;Anne Marie Junca;Paul Cohen-Bacrie.Fertility and Sterility.2004, 5

